Cargando…
Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease
Besides serving as a structural membrane component and intermediate of the glycerolipid metabolism, lysophosphatidic acid (LPA) has a prominent role as a signaling molecule through its binding to LPA receptors at the cell surface. Extracellular LPA is primarily produced from lysophosphatidylcholine...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431043/ https://www.ncbi.nlm.nih.gov/pubmed/34502491 http://dx.doi.org/10.3390/ijms22179575 |
_version_ | 1783750844528721920 |
---|---|
author | Jose, Anu Kienesberger, Petra C. |
author_facet | Jose, Anu Kienesberger, Petra C. |
author_sort | Jose, Anu |
collection | PubMed |
description | Besides serving as a structural membrane component and intermediate of the glycerolipid metabolism, lysophosphatidic acid (LPA) has a prominent role as a signaling molecule through its binding to LPA receptors at the cell surface. Extracellular LPA is primarily produced from lysophosphatidylcholine (LPC) through the activity of secreted lysophospholipase D, autotaxin (ATX). The degradation of extracellular LPA to monoacylglycerol is mediated by lipid phosphate phosphatases (LPPs) at the cell membrane. This review summarizes and interprets current literature on the role of the ATX-LPA-LPP3 axis in the regulation of energy homeostasis, insulin function, and adiposity at baseline and under conditions of obesity. We also discuss how the ATX-LPA-LPP3 axis influences obesity-related metabolic complications, including insulin resistance, fatty liver disease, and cardiomyopathy. |
format | Online Article Text |
id | pubmed-8431043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84310432021-09-11 Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease Jose, Anu Kienesberger, Petra C. Int J Mol Sci Review Besides serving as a structural membrane component and intermediate of the glycerolipid metabolism, lysophosphatidic acid (LPA) has a prominent role as a signaling molecule through its binding to LPA receptors at the cell surface. Extracellular LPA is primarily produced from lysophosphatidylcholine (LPC) through the activity of secreted lysophospholipase D, autotaxin (ATX). The degradation of extracellular LPA to monoacylglycerol is mediated by lipid phosphate phosphatases (LPPs) at the cell membrane. This review summarizes and interprets current literature on the role of the ATX-LPA-LPP3 axis in the regulation of energy homeostasis, insulin function, and adiposity at baseline and under conditions of obesity. We also discuss how the ATX-LPA-LPP3 axis influences obesity-related metabolic complications, including insulin resistance, fatty liver disease, and cardiomyopathy. MDPI 2021-09-03 /pmc/articles/PMC8431043/ /pubmed/34502491 http://dx.doi.org/10.3390/ijms22179575 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jose, Anu Kienesberger, Petra C. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title | Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title_full | Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title_fullStr | Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title_full_unstemmed | Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title_short | Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease |
title_sort | autotaxin-lpa-lpp3 axis in energy metabolism and metabolic disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431043/ https://www.ncbi.nlm.nih.gov/pubmed/34502491 http://dx.doi.org/10.3390/ijms22179575 |
work_keys_str_mv | AT joseanu autotaxinlpalpp3axisinenergymetabolismandmetabolicdisease AT kienesbergerpetrac autotaxinlpalpp3axisinenergymetabolismandmetabolicdisease |